Learn More
Medchemexpress LLC Macupatide acetate | 99.95% | 4984.60 (free base) | 5 MG

Supplier: Medchemexpress LLC HYP10959A5MG
Macupatide acetate is a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist designed for the research of type 2 diabetes. It works by improving insulin secretion responses and enhancing insulin sensitivity. In comparative studies, Macupatide acetate demonstrated a greater improvement in insulin sensitivity than Dulaglutide, even with similar weight reduction, and combining these agents showed additive effects.
- Acts as a GIP receptor agonist.
- Improves insulin secretion responses.
- Enhances insulin sensitivity.
- Potential for research in type 2 diabetes.
- Shows superior insulin sensitivity improvement compared to Dulaglutide.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.